220 related articles for article (PubMed ID: 16525922)
1. [Behavioral pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Spanish validation].
Boada M; Tárraga L; Modinos G; Diego S; Reisberg B
Neurologia; 2006; 21(1):19-25. PubMed ID: 16525922
[TBL] [Abstract][Full Text] [Related]
2. [Neuropsychiatric Inventory-Nursing Home version (NPI-NH): Spanish validation].
Boada M; Tárraga L; Modinos G; López OL; Cummings JL
Neurologia; 2005 Dec; 20(10):665-73. PubMed ID: 16317587
[TBL] [Abstract][Full Text] [Related]
3. [Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)].
Boada M; Cejudo JC; Tàrraga L; López OL; Kaufer D
Neurologia; 2002; 17(6):317-23. PubMed ID: 12084358
[TBL] [Abstract][Full Text] [Related]
4. [Validity and reliability of the Japanese Version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH)].
Shigenobu K; Hirono N; Tabushi K; Ikeda M
Brain Nerve; 2008 Dec; 60(12):1463-9. PubMed ID: 19110758
[TBL] [Abstract][Full Text] [Related]
5. Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic.
Politis AM; Mayer LS; Passa M; Maillis A; Lyketsos CG
Int J Geriatr Psychiatry; 2004 Mar; 19(3):203-8. PubMed ID: 15027034
[TBL] [Abstract][Full Text] [Related]
6. [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono N; Mori E; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Ikeda M
No To Shinkei; 1997 Mar; 49(3):266-71. PubMed ID: 9125732
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia.
Srikanth S; Nagaraja AV; Ratnavalli E
J Neurol Sci; 2005 Sep; 236(1-2):43-8. PubMed ID: 15964021
[TBL] [Abstract][Full Text] [Related]
8. Behavioral outcomes in clinical trials for Alzheimer disease.
Ferris SH; Mackell JA
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267
[TBL] [Abstract][Full Text] [Related]
9. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey.
Yener GG;
Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
Hsieh CJ; Chang CC; Lin CC
Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
[TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease.
Shinagawa Y; Nakaaki S; Hongo J; Murata Y; Sato J; Matsui T; Tatsumi H; Akechi T; Furukawa TA
Int J Geriatr Psychiatry; 2007 Oct; 22(10):951-6. PubMed ID: 17299806
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
14. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
[TBL] [Abstract][Full Text] [Related]
15. Components of behavioral pathology in dementia.
Schreinzer D; Ballaban T; Brannath W; Lang T; Hilger E; Fasching P; Fischer P
Int J Geriatr Psychiatry; 2005 Feb; 20(2):137-45. PubMed ID: 15660411
[TBL] [Abstract][Full Text] [Related]
16. Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research.
Smart KA; Herrmann N; Lanctôt KL
J Geriatr Psychiatry Neurol; 2011 Jun; 24(2):67-72. PubMed ID: 21460341
[TBL] [Abstract][Full Text] [Related]
17. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
Fujikawa T; Takahashi T; Kinoshita A; Kajiyama H; Kurata A; Yamashita H; Yamawaki S
Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
[TBL] [Abstract][Full Text] [Related]
20. Aggressive and impulsive behaviors in Frontotemporal dementia and Alzheimer's disease.
Grochmal-Bach B; Bidzan L; Pachalska M; Bidzan M; Łukaszewska B; Pufal A
Med Sci Monit; 2009 May; 15(5):CR248-54. PubMed ID: 19396041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
